FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

AbbVie Lupron Depot Recall

Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit w…

AbbVie Inc · North Chicago, IL

Risk level
Class II
Reported by FDA
May 7, 2014
Recall ID
D-1287-2014
Check your lot numberHow we source this data

Summary

AbbVie recalled Lupron Depot starting Mar 10, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1287-2014 on May 7, 2014. Reason: Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device. Status: Terminated.

Why it was recalled

Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.

Product description

Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3346-03, UPC 3 00743 34603 9.

Lot numbers, UPCs & expiration codes

Lot #: 1014204, Exp 10/11/15; 1014485, Exp 12/11/16; and 1015007, Exp 12/06/16

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1287-2014
Classification
Class II
Status
Terminated
Recall initiated
Mar 10, 2014
FDA report date
May 7, 2014
Quantity
7362 kits
Recall type
Voluntary: Firm initiated
Recalling firm
AbbVie Inc

Original FDA data

Every field from FDA enforcement report D-1287-2014, exactly as published.

Show all FDA fields
City
North Chicago
State
IL
Status
Terminated
Country
United States
Event ID
67709
Address
1 N Waukegan Rd
Code information
Lot #: 1014204, Exp 10/11/15; 1014485, Exp 12/11/16; and 1015007, Exp 12/06/16
Postal code
60064
Report date
May 7, 2014
Product type
Drugs
Recall number
D-1287-2014
Classification
Class II
Recalling firm
AbbVie Inc
Product quantity
7362 kits
Termination date
Jun 22, 2016
Reason for recall
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3346-03, UPC 3 00743 34603 9.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Mar 10, 2014
Initial firm notification
Letter
Center classification date
Apr 29, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1287-2014, published May 7, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls